186 related articles for article (PubMed ID: 29100462)
1. The role of substance P in epilepsy and seizure disorders.
Wang XF; Ge TT; Fan J; Yang W; Cui RJ
Oncotarget; 2017 Sep; 8(44):78225-78233. PubMed ID: 29100462
[TBL] [Abstract][Full Text] [Related]
2. Involvement of endogenous prostaglandin F2alpha on kainic acid-induced seizure activity through FP receptor: the mechanism of proconvulsant effects of COX-2 inhibitors.
Kim HJ; Chung JI; Lee SH; Jung YS; Moon CH; Baik EJ
Brain Res; 2008 Feb; 1193():153-61. PubMed ID: 18178179
[TBL] [Abstract][Full Text] [Related]
3. Substance P Regulation in Epilepsy.
Chi G; Huang Z; Li X; Zhang K; Li G
Curr Neuropharmacol; 2018; 16(1):43-50. PubMed ID: 28474564
[TBL] [Abstract][Full Text] [Related]
4. Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats.
Ebner K; Rupniak NM; Saria A; Singewald N
Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4280-5. PubMed ID: 15024126
[TBL] [Abstract][Full Text] [Related]
5. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
Meini S; Patacchini R; Maggi CA
Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
[TBL] [Abstract][Full Text] [Related]
6. Peripheral inflammation increases seizure susceptibility via the induction of neuroinflammation and oxidative stress in the hippocampus.
Ho YH; Lin YT; Wu CW; Chao YM; Chang AY; Chan JY
J Biomed Sci; 2015 Jun; 22(1):46. PubMed ID: 26100815
[TBL] [Abstract][Full Text] [Related]
7. Substance P and the Neurokinin-1 Receptor: The New CRF.
Schank JR; Heilig M
Int Rev Neurobiol; 2017; 136():151-175. PubMed ID: 29056150
[TBL] [Abstract][Full Text] [Related]
8. Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens.
Hall JM; Morton IK
Br J Pharmacol; 1991 Feb; 102(2):511-7. PubMed ID: 1707714
[TBL] [Abstract][Full Text] [Related]
9. Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo.
Hirayama Y; Lei YH; Barnes PJ; Rogers DF
Br J Pharmacol; 1993 Mar; 108(3):844-51. PubMed ID: 7682142
[TBL] [Abstract][Full Text] [Related]
10. Effects of JIP3 on epileptic seizures: Evidence from temporal lobe epilepsy patients, kainic-induced acute seizures and pentylenetetrazole-induced kindled seizures.
Wang Z; Chen Y; Lü Y; Chen X; Cheng L; Mi X; Xu X; Deng W; Zhang Y; Wang N; Li J; Li Y; Wang X
Neuroscience; 2015 Aug; 300():314-24. PubMed ID: 26002316
[TBL] [Abstract][Full Text] [Related]
11. Substance P and pain chronicity.
Zieglgänsberger W
Cell Tissue Res; 2019 Jan; 375(1):227-241. PubMed ID: 30284083
[TBL] [Abstract][Full Text] [Related]
12. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
13. Tachykinins and tachykinin receptors in bone.
Goto T; Tanaka T
Microsc Res Tech; 2002 Jul; 58(2):91-7. PubMed ID: 12203708
[TBL] [Abstract][Full Text] [Related]
14. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
Wagner U; Fehmann H; Bredenbröker D; Klüber D; Lange A; Wichert P
Neuropeptides; 1999 Feb; 33(1):55-61. PubMed ID: 10657472
[TBL] [Abstract][Full Text] [Related]
15. Involvement of histamine 1 receptor in seizure susceptibility and neuroprotection in immature mice.
Kukko-Lukjanov TK; Lintunen M; Jalava N; Laurén HB; Lopez-Picon FR; Michelsen KA; Panula P; Holopainen IE
Epilepsy Res; 2010 Jun; 90(1-2):8-15. PubMed ID: 20359868
[TBL] [Abstract][Full Text] [Related]
16. Chemokine CCL2-CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1β Production after Status Epilepticus.
Tian DS; Peng J; Murugan M; Feng LJ; Liu JL; Eyo UB; Zhou LJ; Mogilevsky R; Wang W; Wu LJ
J Neurosci; 2017 Aug; 37(33):7878-7892. PubMed ID: 28716963
[TBL] [Abstract][Full Text] [Related]
17. Central administration of substance P inhibits feeding behavior in chicks.
Tachibana T; Khan MS; Matsuda K; Ueda H; Cline MA
Horm Behav; 2010 Feb; 57(2):203-8. PubMed ID: 19909753
[TBL] [Abstract][Full Text] [Related]
18. Substance P receptor activation induces downregulation of the AMPA receptor functionality in cortical neurons from a genetic model of Amyotrophic Lateral Sclerosis.
Caioli S; Curcio L; Pieri M; Antonini A; Marolda R; Severini C; Zona C
Neurobiol Dis; 2011 Oct; 44(1):92-101. PubMed ID: 21726643
[TBL] [Abstract][Full Text] [Related]
19. Role of substance P in the cardiovascular system.
Mistrova E; Kruzliak P; Chottova Dvorakova M
Neuropeptides; 2016 Aug; 58():41-51. PubMed ID: 26706184
[TBL] [Abstract][Full Text] [Related]
20. Involvement of substance P and the NK-1 receptor in human pathology.
Muñoz M; Coveñas R
Amino Acids; 2014 Jul; 46(7):1727-50. PubMed ID: 24705689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
